ALX Oncology Holdings Inc.
ALXO
$1.93
-$0.08-3.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.13M | 5.36M | 5.38M | 5.09M | 5.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.27M | 18.97M | 23.02M | 22.53M | 23.47M |
| Operating Income | -18.27M | -18.97M | -23.02M | -22.53M | -23.47M |
| Income Before Tax | -17.97M | -17.93M | -22.85M | -22.14M | -25.95M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.97M | -17.93M | -22.85M | -22.14M | -25.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.97M | -17.93M | -22.85M | -22.14M | -25.95M |
| EBIT | -18.27M | -18.97M | -23.02M | -22.53M | -23.47M |
| EBITDA | -17.71M | -18.82M | -22.87M | -22.38M | -22.76M |
| EPS Basic | -0.13 | -0.17 | -0.42 | -0.41 | -0.49 |
| Normalized Basic EPS | -0.08 | -0.11 | -0.26 | -0.26 | -0.27 |
| EPS Diluted | -0.13 | -0.17 | -0.42 | -0.41 | -0.49 |
| Normalized Diluted EPS | -0.08 | -0.11 | -0.26 | -0.26 | -0.27 |
| Average Basic Shares Outstanding | 135.64M | 104.57M | 54.28M | 53.58M | 53.45M |
| Average Diluted Shares Outstanding | 135.64M | 104.57M | 54.28M | 53.58M | 53.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |